DSM's Quali-E slows Alzheimer's disease decline

by Staff
Share This:
Search for similar articles by keyword: [Health and Wellness]

Parsippany, N.J.-based DSM’s Quali-E Vitamin E delayed functional decline in patients with mild to moderate Alzheimer’s disease by 19% or a clinically meaningful delay in progression of 6.2 months over the follow-up period compared to placebo. Further, daily high dose (2,000 I.U./day) supplementation of vitamin E for a long period of time (2.3 years) did not raise safety concerns. The company produces vitamin E for use in human nutrition — dietary supplements, food and beverage and infant nutrition.

The new study by the Department of Veterans Affairs Cooperative Studies Program, titled, “Effects of vitamin E and memantine on functional decline in Alzheimer’s disease,” was published in the Journal of the American Medical Association.

Vitamin E is an essential antioxidant nutrient that helps protect cell membranes by neutralizing free radicals, and also helps to maintain the immune system, support the health of red blood cells and maintain a healthy circulatory system. Vitamin E is found in all body tissues and is important for their health and proper functioning.

For more information, visit www.dsm.com/humannutrition.
Comment on this Article
We welcome your thoughtful comments. Please comply with our Community rules.

 

 


The views expressed in the comments section of Food Business News do not reflect those of Food Business News or its parent company, Sosland Publishing Co., Kansas City, Mo. Concern regarding a specific comment may be registered with the Editor by clicking the Report Abuse link.